Flow density [%] | Tafluprost-treated eyes | Post-surgery eyes | P-value |
---|---|---|---|
Optic nerve area | |||
central | 39.3 ± 11.8 | 32.8 ± 5.9 | 0.04 |
superior | 41.1 ± 9.4 | 32.1 ± 7.4 | 0.001 |
temporal | 32.1 ± 14.9 | 20.9 ± 5.9 | < 0.0001 |
inferior | 42.6 ± 12.4 | 30.4 ± 8.9 | < 0.0001 |
nasal | 23.8 ± 10.1 | 15.7 ± 4.9 | 0.003 |
Macular area, superficial retinal plexus | |||
central | 11.7 ± 3.7 | 8.0 ± 2.7 | 0.78 |
superior | 28.3 ± 13.7 | 23.3 ± 4.8 | 0.21 |
temporal | 17.5 ± 8 | 14.4 ± 3.7 | 0.89 |
inferior | 26.6 ± 10.5 | 19.7 ± 3.2 | 0.03 |
nasal | 25.7 ± 8.7 | 21.3 ± 6.1 | 0.47 |
Macular area, deep retinal plexus | |||
central | 21.1 ± 6.2 | 15.5 ± 5.6 | 0.14 |
superior | 39.5 ± 7.2 | 34.2 ± 9.3 | 0.22 |
temporal | 29.8 ± 5.4 | 25.5 ± 10.4 | 0.55 |
inferior | 31.1 ± 10.9 | 27.0 ± 9.2 | 0.64 |
nasal | 40.4 ± 7.6 | 35.3 ± 10.9 | 0.30 |